TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
ESP Life Sciences Consulting AB
Closing information (x1000 SEK)
| Closing information | 2024/01 | 2023/01 | 2022/01 |
| Turnover |
942
|
771
|
1,003 |
| Financial expenses |
57
|
0
|
5 |
| Earnings before taxes |
199
|
295
|
610 |
| EBITDA |
256
|
286
|
615 |
| Total assets |
1,422
|
1,373
|
1,214 |
| Current assets |
1,366
|
1,335
|
1,209 |
| Current liabilities |
890
|
487
|
554 |
| Equity capital |
517
|
871
|
645 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/01 | 2023/01 | 2022/01 |
| Solvency |
36.4%
|
63.4%
|
53.1% |
| Turnover per employee |
942
|
771
|
1,003 |
| Profit as a percentage of turnover |
21.1%
|
38.3%
|
60.8% |
| Return on assets (ROA) |
18.0%
|
21.5%
|
50.7% |
| Current ratio |
153.5%
|
274.1%
|
218.2% |
| Return on equity (ROE) |
38.5%
|
33.9%
|
94.6% |
| Change turnover |
171
|
-232
|
263 |
| Change turnover % |
22%
|
-23%
|
36% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/01 | 2023/01 | 2022/01 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.